← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 23, 2018Last known activity
May 29, 2025
Timeline
2010s
- Jun 1, 2015
Jacobio Pharmaceuticals Co., Ltd.— Founded
Drugs by trial phase (21 distinct, 24 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Recent trials (35)
- NCT06973564Lead sponsorPhase 1/Phase 2May 29, 2025
- NCT06959615Lead sponsorPhase 1/Phase 2Nov 22, 2024
- NCT06838338OfficialPhase 2Aug 29, 2024
- NCT06416410OfficialPhase 3Aug 7, 2024
- NCT06416410Lead sponsorPhase 3Aug 7, 2024
- NCT06386146Lead sponsorPhase 1/Phase 2Jul 24, 2024
- NCT06008288Lead sponsorPhase 2Nov 30, 2023
- NCT06008288Study directorPhase 2Nov 30, 2023
- NCT06162169Lead sponsorPhase 1Nov 25, 2023
- NCT05920941Lead sponsorPhase 1Jul 8, 2023
- NCT05920941Study directorPhase 1Jul 8, 2023
- NCT05875493Lead sponsorPhase 1May 12, 2023
- NCT05490472Study directorPhase 1/Phase 2Aug 31, 2022
- NCT05490472Lead sponsorPhase 1/Phase 2Aug 31, 2022
- NCT05174585Lead sponsorPhase 1/Phase 2Aug 18, 2022
Details
- Founded
- Beijing, CN Jun 1, 2015
- Last known activity
- May 29, 2025